Pt. Taisho Pharmaceutical Indonesia Tbk

What Pt. Taisho Pharmaceutical Indonesia Tbk does

PT. Taisho Pharmaceutical Indonesia Tbk is a publicly listed Indonesian pharmaceutical company (Tbk designation on the Indonesia Stock Exchange) and a local affiliate of Japan's Taisho Group. Founded in 1970 and headquartered at Millennium Centennial Center in Jakarta, with a manufacturing facility in Depok, Jawa Barat, the company manufactures and markets over-the-counter and ethical pharmaceutical and consumer health products under three principal brands: Counterpain (topical muscle and joint pain relief with heat and cooling variants, trusted in Indonesia for approximately 50 years), Tempra (paracetamol-based pediatric fever medication in multiple flavors), and Theragran (multivitamin supplement with 9 vitamins and 7 minerals). Products are distributed through pharmacies, drugstores, and general retail outlets across Indonesia, and the company serves general consumers plus a secondary segment of athletes and sports organizations supported through partnerships with KONI regional committees and Dispora DKI Jakarta.

The company's go-to-market combines mass-market retail distribution with direct-to-consumer brand-building via celebrity brand ambassadors (Raffi Ahmad and Nagita Slavina appointed in 2022 for Counterpain and Tempra), organic social media presence, health content marketing on its corporate website, and event-driven sports sponsorships. Its stated corporate mission is to contribute to society by creating and offering superior pharmaceuticals and health-related products, with a stated ambition to serve as a production hub for Taisho's Asian counterparts and to explore partnerships with other pharmaceutical companies. Brand equity is its principal commercial asset: Counterpain has won the Top Brand Award in the Muscle Cream category for eight consecutive years (2015-2022) and the Top Social Media Award 2022 with a score of 66.7%. No revenue, pricing, or financial figures are disclosed in the available source material, and no AI, API, or proprietary technology platform is referenced.

Governance is led by a board that includes Directors Yukio Sawada (appointed December 2022) and Toshiyuki Ishii, with Sonny Adi Nugroho serving as Regional Commercial Director. The company maintains a corporate secretary function, an audit committee, and a whistle-blowing system, consistent with its status as an IDX-listed entity. Its CSR footprint includes scholarship support to Universitas Indonesia's Faculty of Pharmacy and community infrastructure work with Universitas Pancasila.

Name

Pt. Taisho Pharmaceutical Indonesia Tbk

Legal name

PT. Taisho Pharmaceutical Indonesia Tbk

Website

https://taisho.co.id

Company type

Public

Founded year

1970

Operating status

Operating

Headcount range

1–10 employees

Short description

PT. Taisho Pharmaceutical Indonesia Tbk is a publicly listed Indonesian OTC pharmaceutical company that manufactures and markets Counterpain muscle cream, Tempra children's fever medication, and Theragran multivitamins to Indonesian consumers through nationwide pharmacy and retail distribution.

Ownership category

akta.pro rank

Product category

Consumer Pharmaceuticals (OTC)

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

akta.pro secondary industry

Multivitamins & Daily Packs (CRADAGAC)

Keywords

• OTC pharmaceutical products
• Muscle pain relief cream
• Children fever medication
• Multivitamin supplements
• Consumer healthcare products

Headquarters

HQ city

Jakarta Pusat

HQ country

Indonesia

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

1. Consumer Healthcare Products: Taisho Pharmaceutical Indonesia manufactures and sells OTC pharmaceutical and health-related products including muscle pain relief creams (Counterpain), fever medications (Tempra), and multivitamins (Theragran) through retail distribution channels in Indonesia.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

PT. Taisho Pharmaceutical Indonesia Tbk manufactures and markets over-the-counter (OTC) and ethical pharmaceutical and health care products for the Indonesian consumer market. The company's core product portfolio consists of Counterpain (muscle pain relief cream available in heat and cooling variants), Tempra (paracetamol-based children's fever medication in various flavors), and Theragran (multivitamin supplement containing 9 vitamins and 7 minerals). Products are distributed through retail and pharmacy channels across Indonesia to address everyday health concerns such as muscle pain, fever, and general wellness.

Product overview

Pt. Taisho Pharmaceutical Indonesia Tbk operates as a pharmaceutical company offering a portfolio of consumer health products. The company's core offerings include Counterpain (muscle cream for pain relief with variants for heat and cooling sensations), Tempra (children's fever medication containing paracetamol in multiple flavors), and Theragran (multivitamin supplements with 9 vitamins and 7 minerals). These products target the Indonesian consumer health market with offerings for pain management, fever relief, and nutritional supplementation.

Differentiator

Problem solved

Functional benefit

Brands

• Counterpain: Muscle cream brand that has won Top Brand Award for 8 consecutive years from 2015 to 2022
• Tempra

Products and services

• Counterpain Counterpain is a topical muscle pain relief cream trusted in Indonesia for approximately 50 years, used for relieving muscle aches, joint pain, sprains, and sports injuries. The brand includes Counterpain Cream (heat sensation) and Counterpain Cool (cooling effect) variants targeting Indonesian consumers seeking topical analgesic solutions.
• Tempra Tempra is a fever-reducing medication for children containing paracetamol (acetaminophen), available in various flavors that appeal to children. It is used as an initial remedy for childhood fevers and is positioned for parents and caregivers seeking trusted pediatric fever treatment.
• Theragran Theragran is a multivitamin supplement containing 9 vitamins and 7 minerals, including vitamins A, C, D, zinc, and magnesium. It is used for immune system support and post-illness recovery by Indonesian consumers seeking general nutritional supplementation.

Quantifiable outcome

• 8 consecutive years Top Brand Award winner (2015-2022)
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• Dispora (Department of Youth and Sports) DKI JakartacoreGTM or Marketing Partner · 25 October 2022Taisho collaborated with Dispora DKI Jakarta Province on October 25, 2022 at Student Sports Training Center (PPOP) Ragunan to provide education regarding athlete fitness improvement, handling sports injuries, and Counterpain product support for athletes.
• KONI (Indonesian National Sports Committee) West JavacoreGTM or Marketing Partner · 12 August 2022Following partnerships with KONI Pusat, KONI Solo, and KONI Jogja, Taisho established cooperation with KONI West Java on August 12, 2022 to provide education about handling sports injuries and Counterpain product support for athletes under KONI West Java guidance.
• KONI (Indonesian National Sports Committee) Central Java and YogyakartacoreGTM or Marketing Partner · 6 June 2022PT. Taisho Pharmaceutical Indonesia established cooperation with KONI Central Java Province (Semarang, June 6, 2022), KONI Surakarta, and KONI Yogyakarta (June 7-8, 2022) for sports injury management through education and Counterpain product support for athletes and coaches.
• Universitas Indonesia - Faculty of PharmacyminorOthers · 9 November 2021Taisho Pharmaceutical Indonesia contributed to society by providing scholarship program with Universitas Indonesia Faculty of Pharmacy, supporting students whose parents faced financial difficulties during the pandemic with tuition fee assistance.
• Universitas PancasilaminorOthers · 1 March 2021Taisho Pharmaceutical Indonesia supported Universitas Pancasila's student engineering association program to provide public toilets, solar water pump, tree planting, and lighting facilities to community in Kampung Pasir Salam, Desa Leuwisadeng, Kabupaten Bogor.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• PT Bayer Indonesia: Bayer's Indonesia consumer health portfolio (e.g., analgesics and topical pain relief) directly overlaps with Counterpain and Tempra. It is a multinational incumbent benchmark for category share and promotional investment.
• PT Dexa Medica: Dexa Medica is a major Indonesian pharmaceutical manufacturer with strong consumer health and supplement brands distributed nationally, comparable to Taisho's OTC and multivitamin (Theragran) positioning.
• PT Kimia Farma Tbk: Kimia Farma combines state-owned pharmaceutical manufacturing with one of Indonesia's largest pharmacy retail networks — a vertically integrated peer that, like Taisho, supplies Indonesian consumers OTC products through extensive domestic retail.
• PT Pfizer Indonesia: Pfizer Indonesia's consumer health division competes in the same analgesics, kids' health, and supplement OTC categories as Taisho's portfolio. As an MNC subsidiary in Indonesia, it represents the multinational competitive threat.
• PT Kalbe Farma Tbk: Kalbe Farma is Indonesia's largest pharmaceutical company with a broad consumer health and OTC portfolio (including pain, supplement, and kids' health brands). It is the most natural broad incumbent comparator for Taisho Indonesia's OTC mix and national retail reach.
• PT Reckitt Benckiser Indonesia: Reckitt Benckiser's Indonesia consumer health business (analgesics, topical relief, hygiene-adjacent health) competes for the same OTC shelf and consumer occasion as Taisho's brands, representing a global FMCG-health incumbent benchmark.

Direct peers

• PT Sanbe Farma: Sanbe Farma is an Indonesian pharmaceutical group with a diversified OTC and ethical pharma portfolio across multiple brands, comparable in scale and channel mix to Taisho's Indonesia OTC operation.
• PT Merck Tbk (Indonesia): Merck Indonesia operates consumer health/OTC and prescription pharma businesses within the local pharma listed universe. It is a relevant listed Indonesian peer for share-of-channel and brand-portfolio comparisons.
• PT Darya-Varia Laboratoria Tbk: Darya-Varia is a publicly listed Indonesian pharmaceutical manufacturer with a consumer health/OTC and prescription mix serving nationwide retail. It is a close scaled-and-listed pharma peer operating in the same Indonesia OTC category set as Taisho.
• PT Tempo Scan Pacific Tbk: Tempo Scan Pacific is a long-established Indonesian OTC and consumer healthcare manufacturer with iconic legacy brands in pain relief, kids' health, and wellness — directly comparable to Taisho's Counterpain/Tempra proposition and Indonesia-domestic distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/taisho-pharmaceutical-indonesia

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pt. Taisho Pharmaceutical Indonesia Tbk